Understanding how immune cells behave to improve cell therapies
Integrated assays of single-cell dynamics and molecular phenotype for cell therapy manufacturing
This study is working on a new way to closely watch and understand immune cells used in treatments, so we can see how they behave and grow, helping doctors predict how well these therapies might work for patients before they start.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cellchorus INC. NIH-funded |
| Lab location | 1 site (Houston, UNITED STATES) |
| Project ID | NIH-11179716 on NIH RePORTER |
What this research studies
This research focuses on developing an advanced analytical platform to better understand the behavior and characteristics of immune cells used in cell therapies. By utilizing a sophisticated AI-based system, the project aims to track and analyze thousands of cells over time, providing real-time insights into their phenotype and metabolism. This information could help predict the effectiveness of therapies before they are administered to patients, ultimately enhancing treatment outcomes. The approach involves optimizing reagents and protocols to identify key cell attributes and measure their growth potential.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients undergoing or considering cell therapy for various types of cancer.
Not a fit: Patients with conditions not related to cancer or those not eligible for cell therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized cell therapies for cancer patients.
How similar studies have performed: Previous research has shown promise in using AI and advanced analytics to improve cell therapy outcomes, indicating a strong potential for success in this approach.
Where this research is happening
Houston, UNITED STATES
- Cellchorus INC. — Houston, United States (Active)
Researchers
- Principal investigator: Berdeaux, Rebecca L — Cellchorus INC.
- Study coordinator: Berdeaux, Rebecca L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.